Literature DB >> 22805456

Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection.

Anthony Chang1, Jocelyn M Moore, Michelle L Cowan, Michelle A Josephson, W James Chon, Roger Sciammas, Zeying Du, Susana R Marino, Shane M Meehan, Michael Millis, Michael Z David, James W Williams, Anita S Chong.   

Abstract

The contribution of T cells and graft-reactive antibodies to acute allograft rejection is widely accepted, but the role of graft-infiltrating B and plasma cells is controversial. We examined 56 consecutive human renal transplant biopsies classified by Banff schema into T-cell-mediated (N = 21), antibody-mediated (N = 18), and mixed (N = 17) acute rejection, using standard immunohistochemistry for CD3, CD20, CD138, and CD45. In a predominantly African-American population (75%), neither Banff classification nor C4d deposition predicted the return to dialysis. Immunohistochemical analysis revealed CD3(+) T cells as the dominant cell type, followed by CD20(+) B cells and CD138(+) plasma cells in all acute rejection types. Using univariate Cox Proportional Hazard analysis, plasma cell density significantly predicted graft failure while B-cell density trended toward significance. Surprisingly T-cell density did not predict graft failure. The estimated glomerular filtration rate (eGFR) at diagnosis of acute rejection also predicted graft failure, while baseline eGFR ≥6 months prior to biopsy did not. Using multivariate analysis, a model including eGFR at biopsy and plasma cell density was most predictive of graft loss. These observations suggest that plasma cells may be a critical mediator and/or an independently sensitive marker of steroid-resistant acute rejection.
© 2012 The Authors. Transplant International © 2012 European Society for Organ Transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22805456      PMCID: PMC3439557          DOI: 10.1111/j.1432-2277.2012.01531.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  40 in total

Review 1.  The alloimmune response and effector mechanisms of allograft rejection.

Authors:  A Arakelov; F G Lakkis
Journal:  Semin Nephrol       Date:  2000-03       Impact factor: 5.299

2.  Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.

Authors:  Audrea M Burns; Anita S Chong
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

3.  Long-term renal allograft survival in the United States: a critical reappraisal.

Authors:  K E Lamb; S Lodhi; H-U Meier-Kriesche
Journal:  Am J Transplant       Date:  2010-10-25       Impact factor: 8.086

Review 4.  The significance of C4d staining with minimal histologic abnormalities.

Authors:  Mark Haas
Journal:  Curr Opin Organ Transplant       Date:  2010-02       Impact factor: 2.640

5.  Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.

Authors:  Khalil El Karoui; Gary S Hill; Alexandre Karras; Luc Moulonguet; Valérie Caudwell; Alexandre Loupy; Patrick Bruneval; Christian Jacquot; Dominique Nochy
Journal:  Kidney Int       Date:  2010-12-22       Impact factor: 10.612

6.  Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).

Authors:  A Loupy; G S Hill; C Suberbielle; D Charron; D Anglicheau; J Zuber; M O Timsit; J P Duong; P Bruneval; Dewi Vernerey; J P Empana; X Jouven; D Nochy; C H Legendre
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

7.  Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.

Authors:  R B Mannon; A J Matas; J Grande; R Leduc; J Connett; B Kasiske; J M Cecka; R S Gaston; F Cosio; S Gourishankar; P F Halloran; L Hunsicker; D Rush
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

8.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

9.  Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Authors:  G Einecke; B Sis; J Reeve; M Mengel; P M Campbell; L G Hidalgo; B Kaplan; P F Halloran
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

10.  The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy.

Authors:  A Haririan; B Kiangkitiwan; D Kukuruga; M Cooper; H Hurley; C Drachenberg; D Klassen
Journal:  Am J Transplant       Date:  2009-10-21       Impact factor: 8.086

View more
  3 in total

1.  Endothelial Cell-Derived Interleukin-18 Released During Ischemia Reperfusion Injury Selectively Expands T Peripheral Helper Cells to Promote Alloantibody Production.

Authors:  Lufang Liu; Caodi Fang; Whitney Fu; Bo Jiang; Guangxin Li; Lingfeng Qin; Jacob Rosenbluth; Gavin Gong; Catherine B Xie; Peter Yoo; George Tellides; Jordan S Pober; Dan Jane-Wit
Journal:  Circulation       Date:  2019-11-20       Impact factor: 29.690

2.  Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis.

Authors:  Stephanie M McGregor; W James Chon; Lisa Kim; Anthony Chang; Shane M Meehan
Journal:  World J Transplant       Date:  2015-12-24

3.  Association of medication non-adherence with short-term allograft loss after the treatment of severe acute kidney transplant rejection.

Authors:  Ahmed Al-Sheyyab; Laura Binari; Mohammed Shwetar; Everly Ramos; Meghan E Kapp; Stefanie Bala; Nikita Wilson; Rachel C Forbes; J Harold Helderman; Khaled Abdel-Kader; Beatrice P Concepcion
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.